Results 11 to 20 of about 94,246 (299)
Nonalcoholic fatty liver disease
Annals of Hepatology, 2004 Nonalcoholic fatty liver disease is a clinicopathologic syndrome that encompasses several clinical entities. The spectrum of conditions ranges from simple steatosis to steatohepatitis, fibrosis and end stage liver disease.
Lafaine M. Grant, Mauricio Lisker-Melman
doaj +5 more sources
Nonalcoholic fatty liver disease
Journal of Lipid Research, 2009 Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and, indeed, worldwide. It has become a global public health issue.
Sandra K. Erickson
doaj +3 more sources
Nonalcoholic fatty liver disease [PDF]
Nature Reviews Disease Primers, 2015 Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are additional findings of portal and lobular inflammation and hepatocyte injury (which characterize nonalcoholic steatohepatitis (NASH)).
Brunt, Elizabeth M +9 more
+19 more sources
Nonalcoholic Fatty Liver Disease [PDF]
Gastroenterology Clinics of North America, 2020 AbstractNonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of the metabolic syndrome (MetS) and comprises one of the largest health threats of the twenty-first century. In this chapter, we review the current state of knowledge of NAFLD and underline the striking similarities with atherosclerosis.
Ding, Lingling +3 more
openaire +5 more sources
Nonalcoholic Fatty Liver Disease [PDF]
Canadian Journal of Gastroenterology and Hepatology, 2018 According to the papers published in this special issue, NAFLD is a serious problem, which each author from their own aspect tried to clarify. Regarding the fact that NAFLD is rarely isolated and that it is correlated with obesity, diabetes type 2, polycystic ovarian syndrome, obstructive sleep apnea, and some cognitive deficits, its pathophysiology ...
Branka Filipović +3 more
doaj +7 more sources
Nonalcoholic fatty liver disease
Canadian Medical Association Journal, 2023 Management of nonalcoholic fatty liver disease (NAFLD) is crucial for type 2 diabetes (T2D) remission because they are linked through the common pathophysiology of insulin resistance and lipotoxicity. One in three patients with T2D has nonalcoholic steatohepatitis leading to fibrosis, cirrhosis, and hepatocellular carcinoma.
Bebawi, Emmanuel +2 more
openaire +4 more sources
Nonalcoholic Fatty Liver Disease [PDF]
North Carolina Medical Journal, 2016 Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is the leading cause of chronic liver disease. Treatments target lifestyle modification and improvement of underlying risk factors. Noninvasive biomarkers for diagnosis and staging of NAFLD and safe, cost-effective treatments for patients with nonalcoholic ...
Tyler, Thrasher, Manal F, Abdelmalek
openaire +4 more sources
Nonalcoholic Fatty Liver Disease
The Korean Journal of Gastroenterology, 2010 Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, and is commonly associated with obesity. The spectrum of NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Fructose ingestion, visceral obesity, and metabolic syndrome are risk factors for liver fibrosis. NAFLD is characterized by
Kathryn, Law, Elizabeth M, Brunt
+7 more sources
Nonalcoholic fatty liver disease
Gastroenterology, 2002 N 'onalcoholic fatty liver disease (NAFLD) includes a spectrum of hepatic pathology that resembles alcohol-induced liver disease but develops in individuals who are not heavy drinkers. NAFLD is likely to be the most common cause of chronic liver disease in many countries and may also potentiate liver damage induced by other agents, such as alcohol ...
Jeanne M, Clark +2 more
openaire +5 more sources
Nonalcoholic fatty liver disease [PDF]
Canadian Medical Association Journal, 2005 Nonalcoholic fatty liver disease is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and ...
Leon A, Adams +2 more
openaire +3 more sources